David L. Steed
Directeur Technique/Scientifique/R&D chez Noveome Biotherapeutics, Inc.
Profil
David L.
Steed is currently the Chief Medical Officer & VP-Medical Affairs at Noveome Biotherapeutics, Inc. He previously worked as a Surgery Professor at the University of Pittsburgh and served as the President of The Wound Healing Society.
Postes actifs de David L. Steed
| Sociétés | Poste | Début |
|---|---|---|
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de David L. Steed
| Sociétés | Poste | Fin |
|---|---|---|
| The Wound Healing Society | President | - |
| University of Pittsburgh | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Health Technology |
| The Wound Healing Society |
